Role of Metoprolol Succinate in the Treatment of Heart Failure and Atrial Fibrillation: A Systematic Review.

American Journal of Therapeutics
Dragos VinereanuDariusz Kozlowski

Abstract

Beta-blockers are one of the most important classes of cardiovascular agents and have been considered a cornerstone therapy in heart diseases, such as heart failure (HF) and atrial fibrillation (AF). Among different beta-blockers, metoprolol is a selective beta1-adrenergic antagonist, which has been extensively used since the 1970s. Although current guidelines include recommendations for the use of controlled-release metoprolol succinate in specific HF and AF indications, and despite extensive clinical experience with metoprolol, comparative evidence on the use of metoprolol succinate compared with other beta-blockers in these indications is limited. We systematically reviewed the data from head-to-head studies directly comparing this compound with other beta-blockers in the treatment of HF or AF. Only clinical trials and observational studies were considered; no other limits were applied. The quality and relevance of retrieved articles were reviewed. A total of 18 articles of the 353 articles identified were selected for inclusion; 12 HF articles and 6 for AF. Additional references were identified from the bibliographies of retrieved articles. The studies show that oral prophylaxis with an appropriate dose of metoprolol may re...Continue Reading

References

Nov 1, 1991·Clinical Pharmacokinetics·M J KendallG Westergren
Jan 1, 1988·European Journal of Clinical Pharmacology·A SandbergJ Sjögren
Nov 5, 1997·Journal of Cardiothoracic and Vascular Anesthesia·C J JakobsenE B Andresen
Oct 13, 2000·Drugs·A Prakash, A Markham
Jan 6, 2006·Srpski arhiv za celokupno lekarstvo·Vera CelićMaksimilijan Kocijancić
Dec 16, 2006·The International Journal of Cardiovascular Imaging·Sakir ArslanHuseyin Senocak
Apr 24, 2010·Journal of the American College of Cardiology·Andrew JabbourChristopher S Hayward
Aug 28, 2012·European Heart Journal·UNKNOWN Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)Doron Zahger
Jan 26, 2013·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Muhammad Fahad KhanMohammad Reza Movahed
Dec 24, 2013·Blood Pressure·Giuseppe ManciaFaiez Zannad
Apr 2, 2014·The Canadian Journal of Cardiology·Luc Poirier, Sheldon W Tobe
Sep 7, 2014·Lancet·Dipak KotechaUNKNOWN Beta-Blockers in Heart Failure Collaborative Group
Nov 5, 2014·Journal of Cardiovascular Electrophysiology·Valentina D A CorinoPyotr G Platonov
Apr 29, 2015·International Journal of Cardiology·Björn PasternakAnders Hviid
Jul 22, 2015·JAMA : the Journal of the American Medical Association·Eric N PrystowskyRichard I Fogel
Nov 20, 2015·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Kara M ChurchJacob Joseph
May 12, 2016·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Mehmet OzaydinAbdullah Dogan
Aug 28, 2016·European Heart Journal·Paulus KirchhofUNKNOWN ESC Scientific Document Group
Nov 20, 2016·Journal of the American College of Cardiology·Dipak KotechaMichiel Rienstra
Oct 19, 2017·European Heart Journal·John G F ClelandUNKNOWN Beta-blockers in Heart Failure Collaborative Group
Oct 23, 2017·The American Journal of Emergency Medicine·Megan E FeeneyRan Ran

❮ Previous
Next ❯

Citations

Nov 2, 2021·Current Reviews in Clinical and Experimental Pharmacology·Asim Ahmed Elnour Ahmed

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.